Feb 27 (Reuters) - Elon Musk's SpaceX is aiming to file confidentially for an initial public offering that could value the ...
SpaceX is targeting filing confidentially for an initial public offering as soon as next month, according to people familiar with the matter, as billionaire Elon Musk’s rocket and satellite company ...
Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. | Generate:Biomedicines is the latest biotech to benefit from a ...
One IPO and six SPACs came to market this past week, and one major issuer joined the pipeline as February comes to a close.
Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range.
Amazon plans up to $50 billion OpenAI investment, tied to IPO plans or achieving artificial general intelligence milestone.
UK-based digital bank Revolut is reportedly eyeing a sale of shares in the second half of 2026 ahead of a potential public ...
Specifically, CoreWeave stock is up an impressive 123% since it began trading on the market in March 2025. However, the ...
ZURICH/HONG KONG, Feb 26 (Reuters) - Syngenta Group plans to launch an up to $10 billion stock market listing in Hong ...
Generate Biomedicines Inc. shares slumped 21% in the company’s trading debut after it raised $400 million in an initial public offering.
Discover how laddering strategies help investors manage risks in bonds and fixed-income products, and learn about its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results